.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: RE36617

« Back to Dashboard

Claims for Patent: RE36617

Title: (Substituted aralkyl) heterocyclic compounds
Abstract:A (substituted-aralkyl)heterocyclic compound of the formula I ##STR1## wherein R.sup.1 is an azido, carbamoyl, cyano, formyl, hydroxy or nitro radical, a 1-6C 1-hydroxyalkyl, alkoxy, alkylcarbamoyl, alkylthio, alkylsulphinyl or alkylsulphonyl radical, a 2-cyanoethyl radical, optionally bearing one to four 1-6C alkyl substituents, or a 2-6C alkanoyl, halogenoalkanoyl, alkanoyloxy, alkanoylamino, dialkylcarbamoyl or alkoxycarbonyl radical; R.sup.2 and R.sup.3, which may be the same or different, are each a hydrogen atom, a 1-6C alkyl, dueterioalkyl or halogenoalkyl radical, or a phenyl or phenyl(1-6C alkyl) radical, in each of which the phenyl may optionally bear one or more substituents; or R.sup.2 and R.sup.3, together with the carbon atom to which they are attached, may form a 3- to 6-membered ring; or R.sup.1 R.sup.2 R.sup.3 C- is a 1,1-dicyanoethyl or trifluoromethylsulphonyl radical; R.sup.4 is a hydrogen or halogen atom, a cyano or nitro radical or a 1-6C alkyl or halogenoalkyl radical; R.sup.5 has any of the values defined above for the group R.sup.1 R.sup.2 R.sup.3 C but is not necessarily the same as R.sup.1 R.sup.2 R.sup.3 C, or has any of the values defined above for R.sup.4 but is not necesarily the same as R.sup.4, or is a carbamoyl, 1-pyrrolidinyl-carbonyl, piperidinocarbonyl, morpholinocarbonyl or nitro radical, a 1-6C alkoxy or halogenoalkoxy radical or a 2-6C alkanoyl or alkoxy-carbonyl radical; A is a methylene or ethylene radical optionally bearing one or more substituents selected from deuterium and halogen atoms, carbamoyl, cyano and hydroxy radicals, 1-6C alkyl and alkoxy radicals, and 2-6C alkanoyloxy radicals provided that when A is linked to R.sup.6 through a nitrogen atom thereof, it may not bear a hydroxy, alkoxy or alkanoyloxy substituent on the carbon atom adjacent to such nitrogen atoms; and R.sup.6 is a 1H-1,2,4-triazol-1-yl, 4H-1,2,4-triazol-4-yl, 1H-imidazol-1-yl, 5-cyano-1H-imidazol-1-yl, 3-pyridyl or 5-pyrimidinyl radical, or a 1H-imidazol-1-yl radical, bearing at the 5-position thereof a 1-6C alkyl substituent which is itself optionally substituted by one or more carbamoyl, cyano, hydroxy or 2-6C alkoxycarbonyl radicals; and provided that when R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are hydrogen, A is a methylene radical and R.sup.6 is a 3-pyridyl radical, R.sup.1 is not a cyano, hydroxy or hydroxymethyl radical, and when R.sup.1 is a hydroxy radical, R.sup.3, R.sup.4 and R.sup.5 are hydrogen, A is a methylene radical and R.sup.6 is 3-pyridyl, R.sup.2 is not a methyl or a 2-chloro-1-methylethyl radical, and provided that when R.sup.1 is a methoxycarbonyl radical, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are hydrogen and A is a methylene radical, R.sub.1 is not a 1H-imidazol-1-yl radical; and the pharmaceutically acceptable acid addition salts thereof.
Inventor(s): Edwards; Philip N. (Bramhall, GB), Large; Michael S. (Stoke-on-Trent, GB)
Assignee: Zeneca Limited (London, GB)
Application Number:08/627,311
Patent Claims: 1. A (substituted-aralkyl)heterocyclic compound of the formula I wherein R.sup.1 is an azido, carbamoyl, cyano, formyl, hydroxy or nitro radical, a 1-6C 1-hydroxyalkyl, alkoxy, alkylcarbamoyl, alkylthio, alkylsulphinyl or alkylsulphonyl radical, a 2-cyanoethyl radical, optionally bearing one to four 1-6C alkyl substituents, or a 2-6C alkanoyl, halogenoalkanoyl, alkanoyloxy, alkanoylamino, dialkylcarbamoyl or alkoxycarbonyl radical; R.sup.2 and R.sup.3, which may be the same or different, are each a 1-6C alkyl, deuterioalkyl or halogenoalkyl radical, or R.sup.1 R.sup.2 R.sup.3 C-is a 1,1-dicyanoethyl or trifluoromethylsulphonyl radical; R.sup.4 is a hydrogen or halogen atom, a cyano or nitro radical or a 1-6C alkyl or halogenoalkyl radical; R.sup.5 has any of the values defined above for the group R.sup.1 R.sup.2 R.sup.3 C, or has any of the values defined above for R.sup.4, or is a carbamoyl, 1-pyrrolidinyl-carbonyl, piperidinocarbonyl, morpholinocarbonyl or nitro radical, a 1-6C alkoxy or halogenoalkoxy radical or a 2 6C alkanoyl or alkoxy-carbonyl radical; A is a methylene or ethylene radical optionally bearing one or more substituents selected from the group consisting of deuterium and halogen atoms, carbamoyl, cyano and hydroxy radicals, 1-6C alkyl and alkoxy radicals, and 2 6C alkanoyloxy radicals provided that when A is linked to R.sup.6 through a nitrogen atom thereof, it may not bear a hydroxy, alkoxy or alkanoyloxy substituent on the carbon atom adjacent to such nitrogen atoms; and R.sup.6 is a 1H-1,2,4-triazol-1-yl or 4H-1,2,4-triazol-4 yl; and the pharmaceutically acceptable acid addition salts thereof..]..[.2. A compound as claimed in claim 1 wherein R.sup.1 is an azido, carbamoyl, cyano, formyl, hydroxy, nitro, hydroxymethyl, 1-hydroxyethyl, 1-hydroxy-1-methylethyl, 1-hydroxypropyl, 1-hydroxy-1-methylpropyl, 1-hydroxy-2-methylpropyl, 1-hydroxybutyl, 1-hydroxypentyl, 1-hydroxyhexyl, methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, sec-butoxy, tert-butoxy, pentyloxy, neopentyloxy, hexyloxy, methylthio, ethylthio, propylthio, isopropylthio, butylthio, isobutylthio, sec-butylthio, tert-butylthio, pentylthio, neopentylthio, hexylthio, methylsulphinyl, ethylsulphinyl, propylsulphinyl, isopropylsulphinyl, butylsulphinyl, isobutylsulphinyl, sec-butylsulphinyl, tert-butylsulphinyl, pentylsulphinyl, neopentylsulphinyl, hexylsulphinyl, methylsulphonyl, ethylsulphonyl, propylsulphonyl, isopropylsulphonyl, butylsulphonyl, isobutylsulphonyl, sec-butylsulphonyl, tert-butylsulphonyl, pentylsulphonyl, neopentylsulphonyl, hexylsulphonyl, acetyl, butyryl, isobutyryl, valeryl, isovaleryl, pivaloyl, hexanoyl, chloroacetyl, dichloroacetyl, trichloroacetyl, trifluoroacetyl, 2,2,2-trichloropropionyl, 2,2,2-trifluoropropionyl, 1,2,2-trifluoropropionyl, 1,2,2,2-tetrafluoropropionyl, perfluoropropionyl, 2,2,3,3,3-pentafluorobutyryl, 2,2-dichloro-3,3,3-trifluorobutyryl, 4,4,4-trifluorovaleryl, 5,5,5-trifluorohexanoyl, acetoxy, propionyloxy, butyryloxy, isobutyryloxy, valeryloxy, isovaleryloxy, pivaloyloxy, hexanoyloxy, acetamido, propionamido, butyramido, isobutyramido, valeramido, isovaleramido, pivalamido, hexanamido, methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, isobutoxycarbonyl, sec-butoxycarbonyl, tert-butoxycarbonyl or pentyloxycarbonyl radical; R.sup.2 and R.sup.3, which may be the same or different, are each a methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, neopentyl, hexyl, trideuteriomethyl, mono-, di or tri-chloromethyl, mono-, di- or trifluoromethyl, 2,2,2-trichloro- or trifluoro-ethyl, 1,2,2-trichloro-or trifluoro-ethyl, pentafluoroethyl, 2,2,3,3,3-pentafluoropropyl, 2,2-dichloro-3,3,3-trifluoropropyl, 4,4,4-trifluorobutyl, 5,5,5-trifluoropentyl or 6,6,6-trifluorohexyl radical, or R.sup.1 R.sup.2 R.sup.3 C is a 1,1-dicyanoethyl or trifluoromethylsulphonyl radical; R.sup.4 is a hydrogen atom, a cyano or nitro radical, or a 1-6C alkyl or halogenoalkyl radical as defined above; R.sup.5 has any of the values defined above for the group R.sup.1 R.sup.2 R.sup.3 C, or has any of the values defined above for R.sup.4, or is a 1-6C alkoxy or a 2 6C alkanoyl or alkoxycarbonyl radical as defined above, or a carbamoyl, 1-pyrrolidinylcarbonyl, piperidinocarbonyl, morpholinocarbonyl or nitro radical, a fluorine, chlorine, bromine or iodine atom, or a mono-, di- or tri-chloromethoxy, mono-, di- or trifluoromethoxy, bromomethoxy, iodomethoxy, 2,2,2-trichloro- or trifluoro-ethoxy, 1,2,2-trichloro- or trifluoro-ethoxy, pentafluoroethoxy, 2,2,3,3,3-pentafluoropropoxy, 2,2-dichloro-3,3,3-trifluoropropoxy, 4,4,4-trifluorobutoxy, 5,5,5-trifluoropentyloxy or 6,6,6-trifluorohexyloxy radical; A is an ethylidene, propylidene, butylidene, 1- or 2-methylethylene, 1,2-dimethylethylene, dideuteriomethylene, difluoromethylene, hydroxymethylene, cyanomethylene or carbamoylmethylene radical, or a 1-hydroxyethylene radical (in which C-1 of the ethylene is linked to the benzene ring) radicals..]..[.3. A compound as claimed in claim 1 which is a hydrochloride, hydrobromide, sulphate, nitrate, phosphate or toluene-p-sulphonate..]..[.4. A compound as claimed in claim 1, 2 or 3 wherein R.sup.1 is a carbamoyl, cyano, hydroxy, 1-hydroxyethyl, methylthio, methylsulphinyl, methylsulphonyl or acetyl radical R.sup.2 and R.sup.3, which may be the same or different, are each a methyl, ethyl, trideuteriomethyl or fluoromethyl radical; R.sup.4 is a hydrogen, fluorine or bromine atom or a cyano, nitro, isopropyl or chloromethyl radical; R.sup.5 is a 1-cyano-1-methylethyl, 1,1-dimethyl-2-oxopropyl, 1-carbamoyl-1-methylethyl, 1-cyano-1-trideuteriomethyl-2,2,2-trideuterioethyl, 1-cyano-2-fluoro-1-(fluoromethyl)ethyl, 1-methyl-1-(methylsulphonyl)-ethyl, 1-cyano-1-ethylpropyl, carbamoyl, 1-piperidinocarbonyl, 1-morpholinocarbonyl, acetyl or methoxycarbonyl radical; A is a methylene, ethylene, ethylidene, isopropylidene, dideuteriomethylene, hydroxymethylene, cyanomethylene, fluoromethylene or difluoromethylene radical, or a 1-hydroxyethylene radical in which the carbon atom bearing the hydroxy substituent is bonded to the benzene ring; and R.sup.6 is a 1H-1,2,4-triazol-1-yl, 4H-1,2,4-triazol-4-yl..]..[.5. A compound as claimed in claim 1 wherein R.sup.1 is a cyano radical, R.sup.5 is a radical of the formula R.sup.1 R.sup.2 R.sup.3 C wherein R.sup.1 is a cyano or hydroxy radical, and R.sup.6 is a 1H-1,2,4-triazol-1-yl radical..]..[.6. A compound as claimed in claim 5 wherein R.sup.2 and R.sup.3, both in the group R.sup.1 R.sup.2 R.sup.3 C and in R.sup.5, are methyl or trideuteriomethyl radicals, and A is a methylene or

dideuteriomethylene radical..].7. A compound .[.as claimed in claim 1 which is.]. .Iadd.selected from the group consisting of .Iaddend.2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]di(2-methylpr opiononitrile), .[.2-[3-(1-hydroxy-1-methylethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)phenyl]-2 -methylpropiononitrile,.]. 2,2'-[5-dideuterio(1H-1,2,4-triazol-1-yl)-methyl-1,3-phenylene]di(2-trideu teriomethyl-3,3,3-trideuteriopropiononitrile) .[.or.]. .Iadd.and .Iaddend.2,2'-[5-dideuterio(1H-1,2,4-triazol-1-yl)methyl-1,3-phenylene]di( 2-methylpropiononitrile).Iadd., or a pharmaceutically acceptable acid

addition salt thereof.Iaddend.. 8. A pharmaceutical or veterinary composition which comprises an effective amount of a compound as claimed in claim .[.1.]. .Iadd.7 .Iaddend.together with a pharmaceutically or

veterinarily acceptable diluent or carrier. 9. A method of treating steroid hormone-dependent tumours which comprises administering to a host in need of such treatment an effective amount of a compound as claimed in

claim .[.1.]. .Iadd.7.Iaddend.. .Iadd.10. A compound of claim 7 which is 2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]di(2-methylpropiononit rile)..Iaddend..Iadd.11. A composition of claim 8 wherein the compound is 2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)1,3-phenylene]di(2-methylpropiononitr ile)..Iaddend..Iadd.12. The method of claim 9 wherein the compound is 2,2'-[5- (1H-1,2,4-triazol-1-ylmethyl)1,3-phenylene]di(2-methylpropiononitrile)..Ia ddend..Iadd.13. A compound of claim 7 which is 2,2'-[5-dideuterio(1H-1,2,4-triazol-1-yl)methyl-1,3-phenylene]di(2-trideut eriomethyl-3,3,3-trideuteriopropiononitrile)..Iaddend..Iadd.14. A compound of claim 7 which is 2,2'-[5-dideuterio(1H-1,2,4-triazol-1-yl)methyl-1,3-phenylene]di(2-methylp

ropiononitrile)..Iaddend..Iadd.15. A compound as claimed in claim 7 which is a hydrocholoride, hydrobromide, sulphate, nitrate, phosphate or toluene-p-sulphonate..Iaddend..Iadd.16. A compound selected from the group consisting of 2,2'-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]di(2-methylpropiononitr ile), 2,2'-[5-dideuterio(1H-1,2,4-triazol-1-yl)methyl-1,3-phenylene]di(2-trideut eriomethyl-3,3,3-trideuteriopropiononitrile) and 2,2'-[5-dideuterio(1H-1,2,4-triazol-1-yl)methyl-1,3-phenylene]di(2-methylp ropiononitrile)..Iaddend.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc